PubMed COVID-19 Clinical Care

CONCLUSIONS: Public health officials should use improved estimates to better understand the burden of COVID-19 and other similar infections.

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: A considerable percentage of the population has received both primary and booster vaccinations, which could potentially provide protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Nearly three years into the COVID-19 pandemic, there is still no effective treatment. In the meantime, more and more evidence indicate that gastrointestinal symptoms are important manifestations of COVID-19. Therefore, the involvement of multiple

No abstract

This study examines the political factors associated with the implementation of a benefit payment policy in Japan during the COVID-19 crisis. The Japanese government announced a universal cash payment program in April 2020, but the payment date

This study explored the effect of emotion regulation styles - integrative emotion regulation (IER), suppressive emotion regulation, and dysregulation-on adolescents' psychosocial adjustment following a Covid-19-related lockdown. 114 mother-adolescent

The COVID-19 pandemic has challenged managers and exposed weaknesses in health systems. In Brazil, the pandemic emerged amid difficulties to work in the Brazilian Unified Health System (SUS) and in health surveillance (HS). The purpose of this

CONCLUSION: No relationship was discovered between the legal measures for SARS-CoV-2 pandemic control and the positive rate and growth rates, as well as the number of hospitalized people. Because it was not feasible to determine the degree of

No abstract

We conducted a cohort study to assess vaccine effectiveness (VE) of coronavirus disease 2019 vaccine combinations on severe acute respiratory syndrome coronavirus 2 critical infection and death among elderly population in Korea. From January to